CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
UHAL
U-Haul Holding Company
There isn't enough reported data to score UHAL yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
UHAL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Under pressure |
UHAL's profitability is currently healthy, but its balance sheet is under pressure. There isn't enough data to rate its revenue and cash flow.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
UHAL PE Valuation
UHAL has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
CAT has the edge over UHAL on the outlook, with more favorable revenue expectations.
UHAL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect UHAL's earnings to grow and its profitability to improve, with its revenue holding steady.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the stronger earnings trend. Trailing diluted EPS is up 31% for CAT versus UHAL down 73%.
UHAL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.59 | +59% |
| Q4 2023 | $3.25 | -34% |
| Q3 2023 | $3.77 | -30% |
| Q2 2023 | $4.20 | -26% |
| Q1 2023 | $4.63 | -19% |
| Q4 2022 | $4.92 | -13% |
| Q3 2022 | $5.38 | +4.3% |
| Q2 2022 | $5.67 | +28% |
| Q1 2022 | $5.73 | +84% |
UHAL's earnings per share have fallen from their peak: $1.00 over the past year, against $5.73 in early 2022.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the stronger quarterly revenue trend. Revenue is up 17% for CAT versus up 8.7% for UHAL.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over UHAL on profitability, with a higher operating margin.
UHAL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.8B | +3.1% |
| Q2 2026 | $1.7B | +3.2% |
| Q1 2026 | $1.3B | +3.1% |
| Q3 2025 | $1.7B | +3.7% |
| Q2 2025 | $1.6B | +5.3% |
| Q4 2024 | $1.4B | +3.7% |
| Q3 2024 | $1.7B | +0.5% |
| Q2 2024 | $1.5B | +0.5% |
UHAL's revenue has picked up after three years of holding roughly level: $1.8B last quarter, up 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | -0.2 points |
| Q2 2026 | 15% | -2.1 points |
| Q1 2026 | -6% | -2.5 points |
| Q3 2025 | 15% | -3.1 points |
| Q2 2025 | 17% | -2.8 points |
| Q1 2025 | -3.5% | N/A |
| Q4 2024 | 11% | -3.9 points |
| Q3 2024 | 18% | -7.4 points |
UHAL's operating margin was 15% last quarter, down 2.1 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the stronger cash trend. Its trailing FCF is up 39% versus its history, compared with UHAL at down 19%.
UHAL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$342.7M | +$103.7M |
| Q2 2026 | -$192.1M | +$126.1M |
| Q1 2026 | -$147.7M | +$242.8M |
| Q3 2025 | -$446.3M | -$12.8M |
| Q2 2025 | -$318.2M | +$191.1M |
| Q4 2024 | -$664.9M | -$230.9M |
| Q3 2024 | -$433.5M | -$14.4M |
| Q2 2024 | -$509.3M | -$201.4M |
UHAL has burned cash in most quarters: −$1.1B over the past year, against −$1.8B the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over UHAL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
UHAL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -1.5M shares |
| 1 year | -0.9% | -1.7M shares |
| 3 years | -0.9% | -1.7M shares |
| 5 years | -0.9% | -1.7M shares |
| Available history | -0.9% | -1.7M shares |
UHAL has 194M diluted shares, down 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10.2M |
| Q2 2026 | $15.6M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
UHAL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 3.9x | Elevated |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 3.6x | Elevated |
| Q4 2023 | 2.4x | Moderate |
| Q3 2023 | 2.1x | Moderate |
| Q2 2023 | 1.9x | Healthy |
| Q1 2023 | 1.9x | Healthy |
| Q4 2022 | 2.0x | Healthy |
UHAL's net debt is about 3.9 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
UHAL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 9.1 | Oversold |
UHAL's weekly RSI is 40 (neutral) and its Stochastic is 9 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
UHAL PE vs Industrials Sector
| Metric | UHAL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
UHAL has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over UHAL on trend strength, trading above more of its moving averages.
UHAL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $57.9 | 3.4% below |
| 20 week MA | $64.8 | 14% below |
| 50 week MA | $57.7 | 3.1% below |
| 100 week MA | $59.9 | 6.6% below |
| 200 week MA | $61.7 | 9.4% below |
UHAL is in a downtrend: it's below all five of its weekly moving averages, and 9.4% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
UHAL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.2 | $44.8 | +20% |
| 2021 | $44.8 | $71.7 | +60% |
| 2022 | $71.7 | $59.5 | -17% |
| 2023 | $59.5 | $71.8 | +21% |
| 2024 | $71.8 | $69.5 | -3.1% |
| 2025 | $69.5 | $51.4 | -26% |
| 2026 YTD | $51.4 | $55.9 | +8.9% |
UHAL has the edge over CAT on returns for 2026, with the stronger performance.